查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493302

美國心臟去顫器市場規模、佔有率和趨勢分析報告：按產品、最終用途和細分市場預測，2024-2030 年

U.S. Defibrillator Market Size, Share & Trends Analysis Report By Product (Implantable Cardioverter Defibrillators, External Defibrillators), By End-Use (Hospital, Pre-hospital), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

美國心臟去顫器市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年美國心臟去顫器市場規模將達43.2億美元，2024年至2030年複合年成長率為7.3%。

技術進步的不斷進步、心臟麻痹和心血管疾病發生率的上升、新興應用的採用不斷增加以及政府和醫療機構的支持舉措是推動該行業成長的一些關鍵因素。

美國心血管疾病盛行率上升是美國心臟去顫器市場的主要動力。例如，根據美國疾病管制與預防中心 (CDC) 的數據，心房顫動 (AFib) 是美國每年約 454,000 例住院患者的首要診斷。這種健康狀況每年導致約 158,000 人死亡。心血管疾病的這種上升趨勢預計將有助於預測期內的市場成長。

老年人口的增加和技術進步預計將對市場成長產生重大影響。 65歲及以上的老年人更容易患心血管疾病（CVD）等慢性疾病。例如，根據 2022 年 11 月題為《老化人口統計：老齡化美國的肖像》的報導，美國約有 5,410 萬人（16.3%）的年齡為 65 歲。因此，不斷成長的老年人口正在推動對這些產品的需求。

美國心臟去顫器市場報告亮點

  • 2023 年，植入式心臟整流去顫器(ICD) 佔據市場主導地位，比重超過 50%。推動此細分市場成長的關鍵因素包括心血管疾病的高盛行率、主要市場中老年人口眾多，以及由於產品應用範圍擴大和技術進步而擴大採用這些設備。
  • 2023年，醫院部門佔銷售額的最大佔有率，因為醫院的心臟病病例數量很高，而且手術也在醫院進行。
  • 由於增加公共使用 AED 可用性的舉措不斷增多，預計 2024 年至 2030 年的複合年成長率將是公共使用市場領域最快的。
  • 美國心臟去顫器市場的參與者包括美敦Medtronic）、雅培（Abbott）、波士頓科學公司（Boston Scientific Corporation）、百多力（BIOTRONIK SE &Co.KG）、微創科學公司（MicroPort Scientific Corporation） 、皇家飛利浦公司（Koninklijke Philips NV）、史賽克（Stryker）、ZOLL Medical Corporation（旭化成）、工業, Ltd.）和西門子醫療保健公司。
  • 2024 年 2 月，植入式醫療設備領域的知名公司 BIOTRONIK 宣布，決定獨家提供其創新的 DX 型號，用於未來的單腔 ICD 植入。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章美國心臟去顫器市場變數、趨勢、範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 美國心臟去顫器市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國心臟去顫器市場：產品預估及趨勢分析

  • 2023年及2030年產品市場佔有率
  • 細分儀表板
  • 美國心臟去顫器市場：按產品分類的前景
  • 2018-2030年市場規模及預測及趨勢分析

第5章美國心臟去顫器市場：最終用途估計與趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 按最終用途分類的美國心臟去顫器市場前景
  • 2018-2030年市場規模及預測及趨勢分析

第6章 競爭狀況

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • List of key distributors and channel partners
    • Key customers
    • 2023年重點公司熱圖分析
  • 公司簡介
    • Medtronic
    • Koninklijke Philips NV
    • Siemens Healthineers
    • Abbott
    • Boston Scientific Corporation
    • BIOTRONIK SE &Co. KG
    • MicroPort Scientific Corporation
    • Nihon Kohden Corporation
    • Stryker
Product Code: GVR-4-68040-277-4

U.S. Defibrillator Market Growth & Trends:

The U.S. defibrillator market size is anticipated to reach USD 4.32 billion by 2030, exhibiting a CAGR of 7.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing technological advancements, rising incidence of sudden cardiac arrest and CVD's, rising adoption in emerging applications, and supportive initiatives by governments & healthcare organizations are some of the key factors fueling industry growth.

The escalating prevalence of cardiovascular diseases in the U.S. serves as a major driving force for the U.S. defibrillator market. For instance, as per the Centers for Disease Control and Prevention (CDC), around 454,000 hospitalizations annually in the U.S. involve Atrial Fibrillation (AFib) as the primary diagnosis. This health condition contributes to around 158,000 annual deaths. This rising trend of cardiovascular diseases is expected to contribute to market growth during the forecast period.

The rising geriatric population and technological advancements are expected to significantly impact market growth. Individuals aged 65 years and above are highly prone to chronic illnesses such as cardiovascular diseases (CVDs). For instance, a November 2022 article titled "Senior Population Statistics: A Portrait of Aging Americans" revealed that approximately 54.1 million (16.3%) people in the U.S. are 65 years or older. Consequently, the growing geriatric population drives the demand for these products.

U.S. Defibrillator Market Report Highlights:

  • Implantable cardioverter defibrillators (ICDs) dominated the market with a share of more than 50% in 2023. Key factors driving this segment growth include the rising adoption of these devices due to the high prevalence of CVDs, the high geriatric population in key markets, and growing product applications and technological advancement.
  • Hospital segment held the largest revenue share in 2023 owing to the higher volume of cardiac cases in hospitals and surgeries performed in hospital settings.
  • The public access market segment is anticipated to register the fastest CAGR from 2024 to 2030 due to the rising initiatives to increase the availability of public access AEDs.
  • Market players operating in the U.S. defibrillator market include Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Koninklijke Philips N.V., Stryker, ZOLL Medical Corporation (Asahi Kasei), Nihon Kohden Corporation, and Siemens Healthineers.
  • In February 2024, BIOTRONIK, a prominent company in the field of implantable medical devices, declared its decision to exclusively provide their innovative DX models for future single-chamber ICD implantations.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End-Use
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End-Use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Defibrillator Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing technological advancements
      • 3.2.1.2. Rising incidence of sudden cardiac arrest and CVD's
      • 3.2.1.3. Supportive initiatives by governments & healthcare organizations
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations & approvals
  • 3.3. U.S. Defibrillator Market Analysis Tools
    • 3.2.3. Industry Analysis - Porter's
      • 3.2.3.1. Supplier power
      • 3.2.3.2. Buyer power
      • 3.2.3.3. Substitution threat
      • 3.2.3.4. Threat of new entrant
      • 3.2.3.5. Competitive rivalry
    • 3.2.4. PESTEL Analysis
      • 3.2.3.1. Political landscape
      • 3.2.3.2. Technological landscape
      • 3.2.3.3. Economic landscape

Chapter 4. U.S. Defibrillator Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Defibrillator Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Implantable cardioverter defibrillators (ICD)
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. S-ICD
      • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. T-ICD
      • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3.2. Single chamber
      • 4.4.1.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3.3. Dual chanmber
      • 4.4.1.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3.4. CRT-D
      • 4.4.1.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. External defibrillators
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Manual ED
      • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Automated ED
      • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Wearable cardoverter defribrillators
      • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Defibrillator Market: End-Use Estimates & Trend Analysis

  • 5.1. End-Use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. Defibrillator Market by End-Use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospital
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Pre-hospital
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Public access market
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Alternate care market
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Home healthcare
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company heat map analysis, 2023
  • 6.4. Company Profiles
    • 6.4.1. Medtronic
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. Koninklijke Philips N.V.
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. Siemens Healthineers
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. Abbott
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Boston Scientific Corporation
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. BIOTRONIK SE & Co. KG
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. MicroPort Scientific Corporation
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. Nihon Kohden Corporation
      • 6.4.8.1. Company overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives
    • 6.4.9. Stryker
      • 6.4.9.1. Company overview
      • 6.4.9.2. Financial performance
      • 6.4.9.3. Product benchmarking
      • 6.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. defibrillators market, by product, 2018 - 2030 (USD Million)
  • Table 3 U.S. defibrillators market, by End-Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. defibrillators market: Market outlook
  • Fig. 9 U.S. defibrillators competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. defibrillators market driver impact
  • Fig. 14 U.S. defibrillators market restraint impact
  • Fig. 15 U.S. defibrillators market: Product movement analysis
  • Fig. 16 U.S. defibrillators market: Product outlook and key takeaways
  • Fig. 17 Implantable cardioverter defibrillators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 S-ICD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 T-ICD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Single chamber market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Dual chamber market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 CRT-D market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 External defibrillators estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Manual ED market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Automated ED market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Wearable cardioverter defribrillators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. defibrillators market: End-Use movement analysis
  • Fig. 28 U.S. defibrillators market: End use outlook and key takeaways
  • Fig. 29 Hospital market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Pre-hospital market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 31 Public access market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 32 Alternate care market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 33 Home healthcare market estimates and forecasts 2018 - 2030 (USD Million)
  • Fig. 34 Market share of key market players - U.S. defibrillators market